Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
AB PHARMA from Oud-Turnhout, company number BE0885207746, closed financial year 2024 with a result of € 36,596 after tax. For that financial year AB PHARMA recorded a gross margin of € 73,272 and equity of € 486,860. Compared with financial year 2023, the result moved from € 59,810 to € 36,596. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.
€ 486,860
▲ 8% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 36,596
▼ 39% vs 2023
Profit after tax over the fiscal year.
€ 3,082
▲ 110% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 466,860.
People and assets in 2024
€ 6,936
▼ 45% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 57,137
▼ 33% vs 2023
€ 28,380 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 1,330
▼ 8% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 4,236
▼ 32% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 118,143 | € 81,212 | € 105,201 | € 73,272 | ▼ 30% |
| Profit after taxes | € 63,554 | € 41,919 | € 59,810 | € 36,596 | ▼ 39% |
| Equity | € 348,535 | € 390,454 | € 450,264 | € 486,860 | ▲ 8% |
| Total debts | € 537,250 | € 487,401 | € 404,979 | € 357,636 | ▼ 12% |
| Cash | € 2,114 | € 2,244 | € 1,468 | € 3,082 | ▲ 110% |
| Land & buildings | € 258,022 | € 248,749 | € 239,476 | € 230,204 | ▼ 4% |
| Retained profit | € 328,535 | € 370,454 | € 430,264 | € 466,860 | ▲ 9% |
| Bank debt | € 150,428 | € 113,943 | € 85,801 | € 57,137 | ▼ 33% |
| Balance sheet total | € 885,786 | € 877,855 | € 855,243 | € 844,496 | ▼ 1% |
Key figures of AB PHARMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to AB PHARMA?
What happened at AB PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 36,596 (▼ 39% vs 2023). filed late Source: NBB ↗
- New establishment in Oud-Turnhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 63,554 profit in 2021 to € 36,596 profit in 2024.
Paid € 79,207 in corporate taxes since 2021.
Best year ever: 2021, with € 63,554 profit.
A new publication or filing at AB PHARMA? We notify you, reason included.
Follow AB PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AB PHARMA are Caroline Asselberghs and Hilde Lydia Brouns. It owns 100% of APOTHEEK DE MEESTER itself.
Directors
According to the 2024 annual accounts
Caroline Asselberghs
Director
Establishments
Establishment units
Physical locations of this company
Beukenlaan 9
2360 Oud-Turnhout
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0885.207.746
- VAT number
- BE 0885.207.746
- Registered office
- Beukenlaan 9, 2360 Oud-Turnhout
- Names & denominations
- AB PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 November 2006
- Peppol
- Active · Active since 26 May 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering